JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.3B |
| 2 |
McDonald's
MCD
|
+$2.2B |
| 3 |
Microsoft
MSFT
|
+$2.07B |
| 4 |
NVIDIA
NVDA
|
+$1.94B |
| 5 |
Goldman Sachs
GS
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$2.77B |
| 2 |
Broadcom
AVGO
|
+$1.88B |
| 3 |
TSMC
TSM
|
+$1.18B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.14B |
| 5 |
Danaher
DHR
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.59% |
| 2 | Healthcare | 9.24% |
| 3 | Consumer Discretionary | 9.21% |
| 4 | Financials | 9.1% |
| 5 | Industrials | 7.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
GraniteShares ETF Trust GraniteShares 2x Long NVDA Daily ETF
NVDL
$3.88B
| $4.57M | ﹤0.01% |
235,476
+17,517
| +8% | +$347K |
|
3177
PUT
Vulcan Materials
VMC
$36.5B
| $4.56M | ﹤0.01% |
18,200
| – | – |
|
3178
PUT
Hartford Financial Services
HIG
$37.8B
| $4.55M | ﹤0.01% |
38,700
| – | – |
|
3179
Adaptive Biotechnologies
ADPT
$3.94B
| $4.55M | ﹤0.01% |
887,833
-14,724
| -2% | -$64.2K |
|
|
APO.PRA
3180
DELISTED
Apollo Global Management Series A
APO.PRA
| $4.54M | ﹤0.01% |
66,712
-37,027
| -36% | -$2.37M |
|
3181
XPeng
XPEV
$11.2B
| $4.52M | ﹤0.01% |
371,399
+10,670
| +3% | +$88.4K |
|
|
SII
3182
Sprott
SII
$3B
| $4.5M | ﹤0.01% |
103,917
+5,129
| +5% | +$217K |
|
3183
iShares High Yield Systematic Bond ETF
HYDB
$1.6B
| $4.5M | ﹤0.01% |
93,620
+50,116
| +115% | +$2.36M |
|
3184
GMO US Quality ETF
QLTY
$5.08B
| $4.49M | ﹤0.01% |
137,839
+63,379
| +85% | +$1.99M |
|
|
TGNA
3185
DELISTED
TEGNA Inc
TGNA
| $4.49M | ﹤0.01% |
284,578
-163,743
| -37% | -$2.39M |
|
3186
Radiant Logistics
RLGT
$408M
| $4.48M | ﹤0.01% |
696,226
-3,617
| -0.5% | -$22K |
|
3187
PUT
Compass
COMP
$9.99B
| $4.47M | ﹤0.01% |
732,400
| – | – |
|
3188
Fidelity Low Volatility Factor ETF
FDLO
$1.45B
| $4.47M | ﹤0.01% |
72,811
-10,246
| -12% | -$605K |
|
3189
Invesco S&P 500 Equal Weight Financials ETF
RSPF
$312M
| $4.46M | ﹤0.01% |
64,637
+36
| +0.1% | +$2.37K |
|
3190
Newell Brands
NWL
$2.66B
| $4.45M | ﹤0.01% |
579,620
-5,493,127
| -90% | -$39.3M |
|
|
MRSN
3191
DELISTED
Mersana Therapeutics
MRSN
| $4.44M | ﹤0.01% |
94,054
+14,978
| +19% | +$661K |
|
3192
PUT
Nutanix
NTNX
$18B
| $4.44M | ﹤0.01% |
75,000
| – | – |
|
3193
Shift4
FOUR
$3.58B
| $4.42M | ﹤0.01% |
49,942
-2,611
| -5% | -$198K |
|
3194
CALL
ResMed
RMD
$32.4B
| $4.42M | ﹤0.01% |
18,100
+16,600
| +1,107% | +$3.71M |
|
3195
PROG Holdings
PRG
$1.7B
| $4.42M | ﹤0.01% |
91,081
-46,587
| -34% | -$1.97M |
|
3196
First Trust Ultra Short Duration Municipal ETF
FUMB
$248M
| $4.41M | ﹤0.01% |
219,355
+75,592
| +53% | +$1.52M |
|
3197
Dimensional National Municipal Bond ETF
DFNM
$2.26B
| $4.41M | ﹤0.01% |
90,795
-403
| -0.4% | -$19.4K |
|
3198
Hudbay
HBM
$11.9B
| $4.4M | ﹤0.01% |
479,297
-1,051,365
| -69% | -$8.48M |
|
3199
Artisan Partners
APAM
$2.99B
| $4.39M | ﹤0.01% |
101,422
-9,398
| -8% | -$388K |
|
3200
BioCryst Pharmaceuticals
BCRX
$2.49B
| $4.39M | ﹤0.01% |
577,129
-170,402
| -23% | -$1.3M |
|
Similar funds
JP Morgan Chase's Q3 2024 Portfolio in Review
As of Q3 2024, JP Morgan Chase held 7,854 positions worth $1.32T, up 7.9% from $1.22T the previous quarter. Its ten largest holdings account for 23% of the portfolio.
JP Morgan Chase's Q3 2024 filing shows 533 new, 3,476 increased, 2,341 reduced and 444 closed positions. Its largest new stake was Smurfit Westrock: 4,472,396 shares worth $221M. The largest sale was Advanced Micro Devices, an estimated $2.77B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- JP Morgan Chase's largest Q3 2024 buy was Smurfit Westrock: 4,472,396 shares worth $221M.
- JP Morgan Chase added most to iShares Broad USD High Yield Corporate Bond ETF in Q3 2024, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q3 2024 reduction was Advanced Micro Devices, cutting an estimated $2.77B.
- JP Morgan Chase fully exited WestRock Company in Q3 2024, selling an estimated $320M.
- JP Morgan Chase's ten largest holdings make up 23% of its $1.32T portfolio in Q3 2024.
- JP Morgan Chase opened 533 new positions and closed 444 in Q3 2024.
- JP Morgan Chase's portfolio value rose 7.9% quarter-over-quarter to $1.32T.
Based on JP Morgan Chase's 13F filing for Q3 2024, filed 8 Nov 2024.